Vol. 1, Issue 12 (2016)
The role of institutional capacity on detection of cervical cancer in Mwala sub county hospital, Machakos County, Kenya
Author(s): Lynette Muthoki J Kiamba, Cholo Wilberforce O, Cristine Zirabumbale
Abstract: Cervical Cancer remains the number one cause of cancer death for women in developing countries including Kenya. It was once among the leading causes of death in developed countries like America; however, incidences of invasive Cervical Cancer have declined steadily over the years in these countries. The decline is primarily attributed to increased use of Pap smear, a screening test procedure that detects cervical changes (Precancerous) before cancer develops. In many of the Kenya Health facilities there is lack of preparedness to detect cervical cancer. The study sought to establish whether Mwala Health facilities were prepared for cervical cancer screening. A descriptive cross sectional study design was used involving both qualitative and quantitative methods of data collection. All health facilities in Mwala Sub County were studied. A structured questionnaire was administered to Health personnel who were in charge of the facility. This was to determine whether they received any funding from the governments to equip the health facilities with the cancer screening equipments and reagents. Checklists were also used to counter check the availability of materials and instruments for screening. The checklists on the other hand were for recording availability of equipments and supplies in health facilities for cervical cancer screening. Data were analyzed using descriptive statistics and presented in frequency tables. The finding was that many of the health facilities lacked equipments and supplies for cervical cancer screening. Therefore Mwala Sub County health facilities were not prepared for cervical cancer screening since the equipment and reagents were not available in most of the health facilities. It therefore means that government should provide funds for procurement of equipments and reagents for cervical cancer screening.